✦ LIBER ✦

Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies

✍ Scribed by Mehdi Hamadani; S. Thomas Kochuparambil; Salman Osman; Aaron Cumpston; Sonia Leadmon; Pamela Bunner; Kathy Watkins; Devi Morrison; Ethan Speir; David DeRemer; Vamsi Kota; Anand Jillella; Michael Craig; Farrukh Awan

Book ID: 116283393
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 173 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.01.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose or intermediate-dose cyclophosp

Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma

✍ Jantunen, E; Putkonen, M; Nousiainen, T; Pelliniemi, T-T; Mahlamäki, E; Remes, K 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

Comparative Cost-Effectiveness of Plerix

Comparative Cost-Effectiveness of Plerixafor Plus Granulocyte-Colony Stimulating Factor Versus Cyclophosphamide Plus Granulocyte-Colony Stimulating Factor for Autologous Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma

✍ C.J. Campen; A.M. Yeager; M.R. Green; E.P. Armstrong 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Risk factors for unsuccessful peripheral

Risk factors for unsuccessful peripheral blood stem cell harvesting using granulocyte-colony stimulating factor mobilization in patients with multiple myeloma

✍ Caroline Pinto Rebello Lacativa; Paulo Gustavo Sampaio Lacativa; Marcia Garnica; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Peripheral blood progenitor cell mobiliz

Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage–colony-stimulating factor and granulocyte–colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation

✍ Asad Bashey; Michael Donohue; Lin Liu; Bridget Medina; Sue Corringham; Anita Iha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Comparative Cost-Effectiveness Of Plerix

Comparative Cost-Effectiveness Of Plerixafor Plus Granulocyte-Colony Stimulating Factor Versus Cyclophosphamide Plus Granulocyte-Colony Stimulating For Autologous Peripheral Blood Stem Cell Mobilization In Patients With Non-Hodgkin's Lymphoma

✍ C.J. Campen; E.P. Armstrong; J.A. Christian; S. Hadeed; A.M. Yeager 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Granulocyte colony-stimulating factor (G

Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSF

✍ Lie, A K W; Hui, C H; Rawling, T; Dyson, P G; Thorp, D; Benic, J; Rawling, C M; 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 54 KB